Glioblastomas account for more than 50% of all malignant brain tumors diagnosed and can affect people of all ages. Unfortunately, the five-year survival rate for people diagnosed with glioblastomas is between 5%-10%. The research conducted by Dr. Eden Tanner's team aims to increase that survival rate by improving the drug delivery system to the brain and making non-surgical treatments more effective.

Recent studies published in medical journals have indicated that glioblastoma diagnosis rates are rising significantly in recent years. One 10-year study of 100 people published in 2020 showed an increase in cases from less than one person in 100,000 to more than four people in 100,000. Although these increases may be driven by improved imaging and diagnostic technology, some researchers believe rates may be rising due to radiation or pollution. Since glioblastoma is one of the deadliest forms of cancer and among the hardest to treat, any research that can be used to improve outcomes is essential -- quickly!

After Dr. Tanner's team was informed that their grant funding would not continue, they immediately re-applied for new funding using a different source. The researchers believe that they will be approved for new grant funding, but the process from grant submission to funding takes about one year. "People living with glioblastoma, frankly, don't have a year," Tanner said. "So we can't stop our work. We have to keep going now." Please give $365 to keep Tanner and her team working on this life-saving research.

In the United States, around 12,000 cases of glioblastoma are diagnosed each year, or about 1,000 per month. Currently, there is no cure for glioblastoma, and most treatments are unfortunately not effective in the long term. Even if a tumor is surgically removed, it almost always recurs. With Dr. Tanner's research, Ole Miss can be at the forefront of fighting this deadly disease and help people survive. Please give $1,000 to keep fighting brain cancer!